Trials / Conditions / Oligodendrogliomas
Oligodendrogliomas
6 registered clinical trials studyying Oligodendrogliomas.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma NCT03027388 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Everolimus With and Without Temozolomide in Adult Low Grade Glioma NCT02023905 | University of California, San Francisco | Phase 2 |
| Completed | Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas NCT02388659 | University of Texas Southwestern Medical Center | — |
| Completed | Clinical Development of MR Spectroscopy and Imaging in Brain Cancers NCT02731521 | University of Texas Southwestern Medical Center | — |
| Terminated | Treatment Strategy for Low-grade Gliomas NCT00897377 | Sun Yat-sen University | Phase 3 |
| Completed | Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours NCT00213876 | University Hospital, Strasbourg, France | — |